MetLife director granted 587 shares

Seitz Michelle reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Seitz Michelle reported acquisition or exercise transactions in this Form 4 filing.

MetLife Inc. director Michelle Seitz received a grant of 587 shares of common stock as part of her non-management director compensation. The shares were awarded at no cash cost to her, reflecting retainer fees paid in stock rather than cash. Following this grant, she holds 1,581 MetLife common shares directly.

Insider Trade Summary

Grant/Award: 587 shares

Grant/Award 1 txn

Insider Seitz Michelle

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	587	$0.00	$0.00

Holdings After Transaction: Common Stock — 1,581 shares (Direct)

Footnotes (1)

1. F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Key Figures

Shares granted: 587 shares Total holdings after grant: 1,581 shares Grant price per share: $0.0000 per share

3 metrics

Shares granted 587 shares Common stock grant on 2026-06-16

Total holdings after grant 1,581 shares Direct MetLife common stock held by Michelle Seitz

Grant price per share $0.0000 per share Compensation grant, not a market purchase

Key Terms

non-management director, retainer fees, common stock, Grant, award, or other acquisition

4 terms

non-management director financial

"MetLife, Inc.'s non-management director compensation arrangements pay a portion"

retainer fees financial

"director compensation arrangements pay a portion of non-management director retainer fees"

common stock financial

"retainer fees in MetLife, Inc. common stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did MetLife (MET) director Michelle Seitz report in this Form 4?

Michelle Seitz reported receiving 587 shares of MetLife common stock. The shares were granted as part of non-management director compensation, increasing her direct holdings to 1,581 shares after the award.

Was the MetLife (MET) director share transaction a market purchase or sale?

The transaction was not a market purchase or sale. It was coded as a grant or award, reflecting non-management director retainer fees paid in MetLife common stock rather than open-market trading.

How many MetLife (MET) shares does Michelle Seitz now own directly?

After the reported grant, Michelle Seitz directly owns 1,581 shares of MetLife common stock. This total includes the 587-share award received as part of her non-management director compensation arrangements.

What does the zero price per share mean in this MetLife (MET) Form 4?

The reported price per share is $0.0000 because the shares were granted as compensation, not bought in the market. They represent stock paid in lieu of cash retainer fees for non-management director service.

How are MetLife (MET) non-management directors compensated in stock?

MetLife’s non-management director compensation arrangements pay a portion of retainer fees in MetLife common stock. In this case, Michelle Seitz received 587 shares as part of those stock-based retainer payments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:11 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Seitz Michelle

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A(1)		587	A	$0	1,581	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)